Cardiology therapeutic breakthroughs and ARNIs implementation in 2026

adicionou um novo artigo Health

2025-12-19 11:06:18 -

Revolutionizing neurohormonal blockade for long term stability The management of cardiac dysfunction has entered a new era with the widespread adoption of agents that target both the renin-angiotensin system and the natriuretic peptide system. In 2026, clinical observations confirmed that this dual-action approach is superior to older monotherapies in preventing the remodeling of heart tissue....

0 Comentários 0 Compartilhamentos 13 Visualizações 0 Anterior